U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07940569) titled 'Glutamine Early Start in Children With SCD Younger Than Five' on Nov. 10.
Brief Summary: A study to assess the efficacy and safety of Glutamine in preventing Vaso Occlusive Crisis in pediatric population less than five years old
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Sickle Cell Disease (SCD)
Intervention:
DRUG: Glutamine
L-Glutamine as an oral powder
OTHER: Standard of Care (SOC)
Standard of care in SCD therapy as Hydroxyurea
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ain Shams University
Information provided by (Responsible Party): Fatma Soliman Elsayed Ebeid, MD, Ain Shams University
Pub...